HIGH-AFFINITY AND SELECTIVITY ON 5-HT(1A) RECEPTOR OF 1-ARYL-4-[1-TETRALIN)ALKYL]PIPERAZINES .2.

被引:101
作者
PERRONE, R
BERARDI, F
COLABUFO, NA
LEOPOLDO, M
TORTORELLA, V
FIORENTINI, F
OLGIATI, V
GHIGLIERI, A
GOVONI, S
机构
[1] PIERREL SPA,DEPT RES & DEV,I-20152 MILAN,ITALY
[2] UNIV MILAN,IST SCI FARMACOL,I-20133 MILAN,ITALY
关键词
D O I
10.1021/jm00006a013
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Several 4-alkyl-1-arylpiperazines that present a tetralin moiety on the terminal part of the side chain were synthesized in order to increase the selectivity on the 5-HT1A versus D-2, alpha(1), sigma, and other 5-HT receptors. Many changes have been effected on previous structures of type 3 (1-aryl-4-[3-(1,2-dihydronaphthalen-4-yl)-n-propyl]piperazines). Several synthetic procedures were followed to obtain the final products, depending on the presence or absence of a double bond, as well as of a heteroatom on the side chain. In the first case versatile use of Grignard reaction was made, whereas in the second one usual synthetic ways were applied. Final compounds were evaluated for in vitro activity on dopamine D-l and D-2, serotonin 5-HT1A, 5-HT1B, 5-HT1C, and 5-HT2, alpha(1) adrenergic, and sigma receptors by radioreceptor binding assay. For the 2-MeO-Ph, 2-pyridyl, and unsubstituted phenyl N-piperazine derivatives, low IC50 values (0.3 nM) on 5-HT1A receptors and high selectivity values were observed.
引用
收藏
页码:942 / 949
页数:8
相关论文
共 20 条
[1]   CHARACTERIZATION OF THE BINDING OF H-3-SCH 23390, A SELECTIVE D-1 RECEPTOR ANTAGONIST LIGAND, IN RAT STRIATUM [J].
BILLARD, W ;
RUPERTO, V ;
CROSBY, G ;
IORIO, LC ;
BARNETT, A .
LIFE SCIENCES, 1984, 35 (18) :1885-1893
[2]  
Cliffe Ian A., 1993, Drugs of the Future, V18, P631
[3]  
ELBERMAWY M, 1992, MED CHEM RES, V2, P88
[4]  
Fuller R.W., 1988, ADV DRUG RES, V17, P349
[5]  
Glennon R. A., 1991, SEROTONIN RECEPTOR S, P19
[6]   NOVEL 1-PHENYLPIPERAZINE AND 4-PHENYLPIPERIDINE DERIVATIVES AS HIGH-AFFINITY SIGMA LIGANDS [J].
GLENNON, RA ;
YOUSIF, MY ;
ISMAIEL, AM ;
ELASHMAWY, MB ;
HERNDON, JL ;
FISCHER, JB ;
SERVER, AC ;
HOWIE, KJB .
JOURNAL OF MEDICINAL CHEMISTRY, 1991, 34 (12) :3360-3365
[7]   RADIOLIGAND BINDING STUDY OF A SERIES OF 5-HT1A RECEPTOR AGONISTS AND DEFINITION OF A STERIC MODEL OF THIS SITE [J].
HIBERT, MF ;
MCDERMOTT, I ;
MIDDLEMISS, DN ;
MIR, AK ;
FOZARD, JR .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1989, 24 (01) :31-37
[8]   GRAPHICS COMPUTER-AIDED RECEPTOR MAPPING AS A PREDICTIVE TOOL FOR DRUG DESIGN - DEVELOPMENT OF POTENT, SELECTIVE, AND STEREOSPECIFIC LIGANDS FOR THE 5-HT1A RECEPTOR [J].
HIBERT, MF ;
GITTOS, MW ;
MIDDLEMISS, DN ;
MIR, AK ;
FOZARD, JR .
JOURNAL OF MEDICINAL CHEMISTRY, 1988, 31 (06) :1087-1093
[9]  
ISHIBE T, 1985, EUR J PHARMACOL, V106, P107
[10]  
KULKARNI S K, 1988, Drugs of Today, V24, P175